Autologous– tag –
-
Syntax Bio & Applied StemCell Partner to Accelerate Allogeneic iPSC Therapies with Low-Immunogenicity Lines and Cellgorithm Platform
Manufacturing Chemist USA Overview Syntax Bio and Applied StemCell have formed a strategic partnership to accelerate programmable iPSC therapy development. This collaboration aims to address key challenges of immune recognition and manuf... -
iPSC-Derived Immune Cells Pave Way for Scalable Allogeneic T-Cell Therapy Platforms in Cancer Immunotherapy
MDPI Global Overview Allogeneic T-cell therapies are rapidly advancing as a promising strategy in cancer immunotherapy to overcome the logistical and manufacturing challenges inherent in autologous approaches. Crucially, induced pluripot... -
European Biotechs Lead Next-Gen Cell & Gene Therapy Manufacturing Innovation: From Scalable Stem Cells to Clinical CAR Treg Trials
PharmTech ヨーロッパ Overview European biotech companies are pioneering next-generation manufacturing technologies crucial for the commercial viability and accessibility of cell and gene therapies (CGTs), prioritizing scalable allogeneic... -
University of Illinois Opens “TORM,” its First cGMP Facility Integrating Cancer Treatment and Regenerative Medicine
University of Illinois College of Medicine USA Overview The University of Illinois has inaugurated the "Translational Oncology and Regenerative Medicine Laboratory (TORM)," its first facility combining cancer treatment and regenerative m... -
Cell Therapy Startups Like Orca Bio and Allogene Lead Cancer & Autoimmune Disease Treatment with Off-the-Shelf Platforms
New Market Pitch USA Overview Cell therapy startups such as Orca Bio and Allogene, utilizing off-the-shelf platforms, are spearheading advancements in allogeneic and iPSC-derived therapies for cancer and autoimmune diseases. Key differen... -
University of Illinois Opens TORM, First Lab Combining Cancer Treatment and Regenerative Medicine, Featuring Automated Bioproduction Biofoundry
University of Illinois Urbana-Champaign (Carle Illinois College of Medicine) USA Overview The University of Illinois Urbana-Champaign has established the Translational Oncology and Regenerative Medicine Laboratory (TORM), the first resea... -
BioProcess International Advocates for Building a Distributed Model for Future Autologous Cell Therapy Manufacturing
BioProcess International Netherlands Overview BioProcess International and IB Communications held a video roundtable proposing the construction of a distributed manufacturing model for the future of autologous cell therapy biomanufacturi... -
New Market Pitch Evaluates Top Cell Therapy Startups Including Orca Bio, Cellares, and Kelonia: Differentiated by Clinical, Manufacturing, and Strategic Advancements
New Market Pitch USA Overview New Market Pitch selected ten leading cell therapy startups—Orca Bio, Kyverna, Cabaletta Bio, Cellares, Immatics, Iovance, Sana, Kelonia, Orna, and Dispatch Bio—evaluating their regulatory maturity, clinical... -
BioProcess International Advocates for Distributed Hybrid Model in Autologous Cell Therapy Manufacturing
BioProcess International USA Overview A BioProcess International video roundtable discussed the future of distributed biomanufacturing for autologous cell therapies. With centralized manufacturing struggling to scale and point-of-care mo... -
Strategic CDMO Partnerships Accelerate in Cell and Gene Therapy Market to Tackle Manufacturing and Cost Challenges
Contract Pharma USA Overview The burgeoning cell and gene therapy (CGT) market is increasingly relying on strategic CDMO partnerships to navigate complex manufacturing and cost challenges. Sponsors are actively seeking CDMOs with special...
